The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital.

Slides:



Advertisements
Similar presentations
Chronic kidney disease
Advertisements

Chronic kidney disease
The National Kidney Foundations Kidney Early Evaluation Program TM The National Kidney Foundations Kidney Early Evaluation Program TM Essex-Passaic Wellness.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
CKD in individuals with CKD
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
FFBI Change Concepts FFBI Change Concept #12 Presented by: Ellen DePrat, MSN, RN, NE, CPHQ Project Coordinator - HealthInsight (QIO for Nevada/Utah) October.
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
Chapter 1: CKD in the General Population 2014 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.
Welch Center Uniting Medicine & Public Health Prevalence of Albuminuria, and its Relationship to Decreased GFR and Outcomes Josef Coresh, MD, PhD Director,
Chronic Kidney Disease Jacqueline Annand – CKD Nurse Mary Simpson – CKD Nurse Joyce Mackie – Pre Dialysis/Transplant liaison Sister.
Lesley Stevens MD Tufts-New England Medical Center
CHRONIC KIDNEY FAILURE
Reference Cooper BA, and the IDEAL study group. A randomized controlled trial of early versus late initiation of dialysis. N Engl J Med [Accessed.
Prevalance of Chronic Kidney Disease 26 million people have diagnosed chronic kidney 26 million people have diagnosed chronic kidney disease (CKD) ( National.
Use of clinical laboratory databases to enable early identification of patients at highest risk of developing end- stage kidney disease Dr David Kennedy.
Section 1: CKD Epidemiology. The Problem Chronic Kidney Disease is an epidemic worldwide –Growth 6-8% per annum of dialysis patients Accumulating data.
Early Detection and Prevention of Renal Failure Linda Fried, MD, MPH.
This lecture was conducted during the Nephrology Unit Grand Ground by a Sub-intern under Nephrology Division, Department of Medicine in King Saud University.
Section 4: Managing progression of CKD. Glomerulosclerosis Reduction in number of functioning glomeruli Increased blood flow to remaining nephrons Intraglomerular.
CKD: the primary/secondary care interface Daniel Ford Consultant Renal Physician UHCW.
RENAL DISEASE IN DIABETES
Chronic kidney disease Mr James Hollinshead Public Health Analyst East Midlands Public Health Observatory (EMPHO) UK Renal Registry 2011 Annual Audit Meeting.
An update on chronic renal failure: follow-up and when to refer ? Assoc Prof Johan Rosman Renal Department Waitemata DHB
6 / 5 / RENAL DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED INTO 3 GROUPS BY BASELINE GLOMERULAR FILTRATION RATE (GFR) ALLHAT.
SM Gatmiri, MD, Nephrologist Imam Khomeini Hospital,
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
SHEFFIELD GUIDELINES: RENAL DISEASE IN DIABETES Dr Jenny Stephenson GP, Stannington Medical Centre
Irbesartan Diabetic Nephropathy Trial (IDNT) Collaborative Study Group N Eng J Med 345: , 2001 Edmund J. Lewis, M.D. Muehrcke Family Professor of.
Section 5: Configuration of healthcare to manage CKD.
Section 3: CKD, CVD and mortality. Cardiovascular diseases in CKD patients Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic.
Section 2: Detection of CKD. What Tests Are Available? Direct GFR measurement –Inulin clearance –Radionuclides –Iohexol clearance 3 hr CrCl with Cimetidine.
Chronic Kidney Disease (CKD) Epidemiology A NEW EPIDEMIC: CHRONIC KIDNEY DISEASE IN GENERAL POPULATION REAL PREVALENCE AND RELATED FACTORS Josep M. Galceran,
Expert Systems in Renal Disease Kent Renal ServiceUniversity of KentSalford Hospital Chris Farmer Bernhard Klebe Jean IrvingDonal O’Donoghue Paul StevensRoger.
Chapter 1: CKD in the General Population 2015 A NNUAL D ATA R EPORT V OLUME 1: C HRONIC K IDNEY D ISEASE.
What is PD2010_023 Policy Directive from NSW DOH, 15th April 2010
ALLHAT 6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (3 GROUPS by GFR)
6/5/ CARDIOVASCULAR DISEASE OUTCOMES IN HYPERTENSIVE PATIENTS STRATIFIED BY BASELINE GLOMERULAR FILTRATION RATE (4 GROUPS by GFR) ALLHAT.
Lab (5): Renal Function test (RFT) (Part 2) T.A Nouf Alshareef T.A Bahiya Osrah KAU-Faculty of Science- Biochemistry department Clinical biochemistry lab.
1 به نام خدا. Epidemiology of chronic kidney disease 2.
PUTTING PREVENTION FIRST Vascular Checks Dr Bill Kirkup Associate NHS Medical Director.
Am J Kidney Dis. 2014;63(6): R3 박세정 /prof. 이태원 Comparative Effectiveness of Early Versus Conventional Timing of Dialysis Initiation in Advanced.
Prevalence of Chronic Kidney Disease in an Urban Population
Original article Chronic Renal Failure A Neglected Comorbidity of COPD Raffaele Antonelli Incalzi, MD; Andrea Corsonello, MD; Claudio Pedone, MD; Salvatore.
Chronic Kidney Disease (CKD) Dr. Sham Sunder. Now we know why the titanic sank !! < 0.5 % 5- 10%
Section 1: CKD Epidemiology
National service framework for Renal
Figure 1.1 Prevalence of CKD by stage among NHANES participants,
Section 4: Managing progression of CKD
Section 6: Management in primary care
Lab (5): Renal Function test (RFT) (Part 2)
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
Section 3: CKD, CVD and mortality
Chapter 1: CKD in the General Population
Estimated GFR in Diabetes
Renal Pharmacy Group Beginners Lectures 2018
Chapter 1: CKD in the General Population
به نام خدا.
Section 5: Configuration of healthcare to manage CKD
Meeting the challenges of the new K/DOQI guidelines
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
American Journal of Kidney Diseases
Age-Standardized Rates of Death from Any Cause According to the Estimated GFR among 1,120,295 Ambulatory Adults Alan S.Go et al. N Engl J Med 2004; 351:
ASSIST CKD: Scaling up an intervention to improve the management of progressive chronic kidney disease.
Presentation transcript:

The management of renal problems in primary care Hugh Gallagher Consultant Nephrologist St Helier Hospital

The “epidemic” of CKD What is a typical CKD patient? A role for increasing primary care involvement? How can we achieve this?

The “epidemic” of CKD What is a typical CKD patient? A role for increasing primary care involvement? How can we achieve this?

Nephrology workload “High” maintenance –Dialysis (HD/PD) –Predialysis –Acute renal failure –Acute transplantation –“Special”, eg vasculitis “Low” maintenance –CKD –Long term transplant follow up –Hypertension –Others

“Local health organisations can work with pathology services and networks to develop protocols for measuring kidney function by serum creatinine concentration together with a formula-based estimation of glomerular filtration rate (eGFR), calculated and reported automatically by all clinical biochemistry laboratories.” Renal NSF Part 2, Dept of Health, 2004

MDRD formula –Age –Sex –Creatinine –Ethnicity (black vs. non-black) Cockcroft-Gault formula –Age –Sex –Creatinine –Weight

AgeSexWeight (kg) Serum creatinine ( μ mol/L) Estimated GFR (ml/min) 60M70150

AgeSexWeight (kg) Serum creatinine ( μ mol/L) Estimated GFR (ml/min) 60M

AgeSexWeight (kg) Serum creatinine ( μ mol/L) Estimated GFR (ml/min) 60M M60170

AgeSexWeight (kg) Serum creatinine ( μ mol/L) Estimated GFR (ml/min) 60M M

AgeSexWeight (kg) Serum creatinine ( μ mol/L) Estimated GFR (ml/min) 60M M F60170

AgeSexWeight (kg) Serum creatinine ( μ mol/L) Estimated GFR (ml/min) 60M M F

K-DOQI Classification of CKD StageGFR (ml/min) Description 1> 90 1 Kidney damage with normal or  GFR Kidney damage with mild  GFR Moderate  GFR Severe  GFR 5< 15Kidney failure Chronic kidney disease is defined as either kidney damage or GFR 3 months. 1 Kidney damage is defined as pathological abnormalities or markers of damage, including abnormalities in urinalysis or imaging

K-DOQI Classification of CKD StageGFR (ml/min) DescriptionPrevalence (%) 1> 90 1 Kidney damage with normal or  GFR Kidney damage with mild  GFR Moderate  GFR Severe  GFR 0.2 5< 15Kidney failure0.2 Chronic kidney disease is defined as either kidney damage or GFR 3 months. 1 Kidney damage is defined as pathological abnormalities or markers of damage, including abnormalities in urinalysis or imaging

Prevalence of Unreferred CKD in East Kent East Kent population 601,000 Small ethnic population Study period Oct Sept 2002 Using opportunistic serum creatinine –Monthly screening of Chemical Pathology Database –Review after two months

Males serum creatinine  180  mol/L Females serum creatinine  135  mol/l Approximate to GFR < 30-40ml/min/1.73m 2 CKD definition

Prevalence 5554pmp Median Age 82 (18-103) Median GFR 28.0 ( ) 41.8% Male 17.8% diabetes CRF Population CRF Population Calculated GFR (mls/min) Number of cases Prevalence 0.55% Median Age 82 (18-103) Median GFR 28.0 ( ) 41.8% Male 17.8% diabetes CKD population

Unreferred CRF population Unreferred CRF population Median Age 83 (18-103) Median GFR 28.5 ( ) 39.2% Male 17.7% Diabetes Calculated GFR (mls/min) Number of patients Prevalence 0.47% Median Age 83 (18-103) Median GFR 28.5 ( ) 39.2% Male 17.7% Diabetes Unreferred population

< ( ) 23.4 ( ) eGFR (ml/min/1.73m) < Women (%) < (18-103)70 (18-91)Age (yrs) Prevalence (pmp) PUnreferredKnown John et al AJKD 2004;43: DOD/ Comparison of known and unreferred populations

In real money... GP practice 10,000 patients –Stage 3 CKD: 500 patients –Stage 4 CKD: 20 patients –Stage 5 CKD: 20 patients –Unreferred stage 4 and 5: 28 patients Renal unit, serving 1.8 million population –Unreferred stage 4 and stage 5: 5,100 patients

The introduction of eGFR will facilitate early recognition of CKD It will also result in increased awareness of advanced CKD previously not recognised as such A “coping” strategy needs to be developed before eGFR reporting is introduced

The “epidemic” of CKD What is a typical CKD patient? A role for increasing primary care involvement? How can we achieve this?

Causes of CKD in the elderly

Functional consequences of CKD Hypertension Anaemia Disorders of Ca/Pi/PTH metabolism –renal osteodystrophy –vascular calcification

Snapshot of a CKD population in primary care GFR estimated on patients from 12 practices in Surrey, Kent and Greater Manchester 19% of sample (5% population) stage 3-5 CKD mean age 74 years (control 57 years) 75% stage 3-5 (22% control) co-existing circulatory disease 25% stage 3-5 (men) prostatic disease 15% stage 3-5 anaemic by WHO (4% requiring treatment by European Best Practice guidelines) 3% recorded as having a renal disease

Comorbidities in CKD

The “epidemic” of CKD What is a typical CKD patient? A role for increased primary care involvement? How can we achieve this?

Most CKD patients are stable

Cardiovascular diseases in CKD Damage to the heart (Uraemic cardiomyopathy ) Damage to the arteries (Uraemic arteriopathy)

Uraemic Cardiomyopathy Thickening of the wall Dilation of the heart Myocardial scarring Calcification Conduction defects

Uraemic Arteriopathy Thickening of the wall Atherosclerosis Stiffening of the artery Calcification

Adapted from Levey AS et al. Am J Kidney Dis 1998; 32: Cardiovascular Mortality Rates are Higher among Dialysis Patients General population: male General population: female Dialysis: male Dialysis: female

Go, A. S. et al. N Engl J Med 2004;351: Adjusted Hazard Ratio for Death from Any Cause, Cardiovascular Events, and Hospitalization among 1,120,295 Ambulatory Adults, According to the Estimated GFR

Most renal patients die of CV causes well before they reach ESRD Their management is therefore that of their CV risk

Risk factors CVS DISEASE –Hypertension –Dyslipidaemia –Smoking –Obesity –Lack of exercise PROGRESSION –Hypertension –Dyslipidaemia –Smoking –Obesity –Lack of exercise

Patient choice…..

“No added value” consultations “The BP today was too high at 160/90. I have not made any changes today but suggest you repeat it in 2 weeks….” Where are blood tests performed?

Protocol-based nurse-led clinics IT support GMS contract

The “epidemic” of CKD What is a typical CKD patient? A role for increasing primary care involvement? How can we achieve this?

Principles Collaborative approach between primary and secondary care Concise practice guidelines for referral and management Role for practice and community-based specialist nurses Support from nephrologists for all stages Dedicated nephrology care for predialysis and deteriorating

Dangers Late referral Missing ARF Undertreatment of renal anaemia and abnormalities of bone biochemistry Issues around clinical responsibility Workload

Short-term goals Education Pilot and issue guidelines for –management of newly discovered abnormal eGFR in primary care –management of CKD (including indications for referral) in primary care Implement eGFR reporting by St Helier laboratories Link the management of CKD to that of CV risk

Longer-term goals Specialist nurse-led community based renal clinics Protocol-based approach for management of renal anaemia and bone disease in the community Renegotiation of GMS contract Commissioning arrangements

The nephrologist’s view

The GP’s view